recurrent extrahepatic bile duct cancer
Showing 1 - 25 of >10,000
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +6 more
- PET scan
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 21, 2022
Recurrent Extrahepatic Bile Duct Stones asLate Complication of
Recruiting
- Intrahepatic Bile Duct Stone
- Choledocholithiasis
-
Xi'an, Shaanxi, ChinaXijing Hospital of Digestive Diseases
Sep 14, 2023
Recurrence After Whipple's (RAW) Study
Active, not recruiting
- Pancreatic Cancer
- +13 more
- Pancreaticoduodenectomy
-
Clayton, Victoria, Australia
- +28 more
Jan 13, 2023
Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic
Active, not recruiting
- Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
- +27 more
- Durvalumab
- Guadecitabine
-
Los Angeles, California
- +2 more
Aug 5, 2022
Common Bile Duct Stone, Abdominal Massage Trial in Xi'an (Abdominal massage)
Recruiting
- Common Bile Duct Stone
- Abdominal Massage
- Abdominal massage
-
Xi'an, Shaanxi, ChinaXijing Hospital of Digestive Diseases
Jun 8, 2023
Sphincterotomy, Endoscopic Trial in Beijing (EST, ECPP)
Recruiting
- Sphincterotomy, Endoscopic
- EST
- ECPP
-
Beijing, Beijing, ChinaPeking University Third Hospital
May 31, 2023
Bile Duct Cancer Trial (envolizumab , sovalteinib)
Not yet recruiting
- Bile Duct Cancer
- envolizumab , sovalteinib
- (no location specified)
Jun 20, 2023
Looking At Bile Duct Cancer Patient Experience Patterns in
Not yet recruiting
- Bile Duct Cancer
- (no location specified)
Jan 20, 2023
Bile Duct Obstruction, Extrahepatic Trial in Korea, Republic of (Cytology staining)
Recruiting
- Bile Duct Obstruction, Extrahepatic
- Cytology staining
-
Seongnam, Bundang-gu, Korea, Republic of
- +4 more
Aug 2, 2022
Bile Duct Adenocarcinoma Trial in Hangzhou (surufatinib plus cadonilimab)
Recruiting
- Bile Duct Adenocarcinoma
- surufatinib plus cadonilimab
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Oct 15, 2023
Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)
Not yet recruiting
- Biliary Tract Diseases
- +5 more
- no interventions
- (no location specified)
Jun 1, 2023
Multi-Platform Profiling of Resected Biliary Tract Cancer
Recruiting
- Biliary Tract Cancer
- +7 more
- Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
-
Chicago, Illinois
- +1 more
Jan 23, 2023
Inoperable Disease, Bile Duct Cancer Trial in Cluj-Napoca (Endoscopic ultrasound with fine needle biopsy)
Recruiting
- Inoperable Disease
- Bile Duct Cancer
- Endoscopic ultrasound with fine needle biopsy
-
Cluj-Napoca, Cluj, RomaniaIRGH "O. Fodor"
Jun 14, 2022
Bile Duct Stenosis Trial (cholangioscopy)
Not yet recruiting
- Bile Duct Stenosis
- cholangioscopy
- (no location specified)
Jun 14, 2023
Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)
Not yet recruiting
- Bile Duct Cancer
- +4 more
- Gemcitabine
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 23, 2023
Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,
Active, not recruiting
- Advanced Bile Duct Carcinoma
- +17 more
- Irinotecan
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jan 5, 2023
Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer
Recruiting
- Metastatic Colorectal Cancer (Mcrc)
- +7 more
- Floxuridine
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)
Active, not recruiting
- Breast Cancer
- +11 more
- radionuclide imaging
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 20, 2022
Pancreatic Cancer, Common Bile Duct Diseases, Periampullary Carcinoma Trial in Hengyang (Intermediate approach, Standard
Not yet recruiting
- Pancreatic Cancer
- +2 more
- Intermediate approach
- Standard approach
-
Hengyang, Hunan, ChinaThe First Affiliated Hospital of University of South China
Dec 26, 2022
Pancreatic Cancer, Common Bile Duct Diseases, Periampullary Carcinoma Trial (laparoscopic pancreaticoduodenectomy, Robot
Not yet recruiting
- Pancreatic Cancer
- +2 more
- laparoscopic pancreaticoduodenectomy
- Robot Pancreaticoduodenectomy
- (no location specified)
Feb 23, 2023
Pancreatic Cancer, Common Bile Duct Diseases, Periampullary Carcinoma Trial (Robot-assisted Pancreaticoduodenectomy)
Not yet recruiting
- Pancreatic Cancer
- +2 more
- Robot-assisted Pancreaticoduodenectomy
- (no location specified)
Feb 23, 2023
Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,
Not yet recruiting
- Biliary Cancer
- +2 more
- oxaliplatin
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
May 13, 2023
Pancreatic Cancer, Cholangiocarcinoma Trial in Amsterdam ([68Ga]Ga-FAPI-46 PET/CT)
Recruiting
- Pancreatic Cancer
- Cholangiocarcinoma
- [68Ga]Ga-FAPI-46 PET/CT
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location VUmc
Jul 13, 2023
Ampullary Cancer, Bile Duct Cancer, Pancreas Cancer Trial in Zhanjiang (Modified Blumgart Anastomosis in LPD, conventional
Enrolling by invitation
- Ampullary Cancer
- +3 more
- Modified Blumgart Anastomosis in LPD
- conventional Blumgart anastomosis in LPD
-
Zhanjiang, Guangdong, ChinaThe Affiliated Hospital of Guangdong Medical University
Oct 7, 2023
Hilar Cholangiocarcinoma Trial in Leipzig (Photosensitizer, Radiofrequency ablation (RFA))
Recruiting
- Hilar Cholangiocarcinoma
- Photosensitizer
- Radiofrequency ablation (RFA)
-
Leipzig, GermanyUniversity Hospital of Leipzig, Department of Gastroenterology
Oct 14, 2022